Thrombocytopenia may result from hypoproliferation in marrow, or peripheral destruction of platelets. Distinction between these two categories is usually made by bone marrow examination. Some studies in literature hint that platelet volume indices are differentially altered in various causes of thrombocytopenia. The present study was aimed at investigating the role of platelet volume indices in the differential diagnosis of thrombocytopenia. Sixty healthy controls and 60 patients (study group) with thrombocytopenia (platelet count < 150 x 10(9)/l) were included in the study. The study group was divided into two categories: hypoproliferative (megaloblastic and non-megaloblastic) and destructive thrombocytopenia. Clinical features, platelet counts and platelet indices were studied in both these categories, and statistical analysis was performed. Platelet counts in the three categories of thrombocytopenia were statistically not different. All the three platelet volume indices were significantly higher in megaloblastic group as compared to the non-megaloblastic hypoproliferative category. Platelet distribution width (PDW) was significantly different between destructive thrombocytopenia and non-megaloblastic hypoproliferative groups. In conclusion, we recommend the division of hypoproliferative category of thrombocytopenia into megaloblastic and non-megaloblastic types. Alterations in platelet indices, especially PDW can differentiate non-megaloblastic hypoproliferative category from both the destructive and megaloblastic thrombocytopenia category. These simple indices can be routinely used in the initial evaluation of a patient with thrombocytopenia.

McMonnies' and Ocular Surface Disease Index (OSDI) questionnaires were used to estimate the prevalence of dry eye among 400 consecutive patients aged >40 years attending the ophthalmology outpatient department of the Lady Hardinge Medical College and associated Smt Sucheta Kriplani Hospital, in New Delhi, India. These estimates were then compared with the results of various clinical tests and examinations of the same patients, including Schirmer's tests, evaluations of tear-film breakup times and fluorescein staining of corneas. Although the overall prevalence of dry eye based on OSDI was 29.25%, there was considerable age- and gender-related variation in this parameter. Compared with the younger patients, those aged >or=80 years were more likely to have OSDI that were indicative of dry eye (41.2%), and the women investigated were more likely to have dry eye (as indicated by OSDI) than the men (27% v. 12%). Occupation, however, appeared to have no effect on the risk of dry eye (P=0.952). Grittiness was the commonest complaint reported. McMonnies' indices (MMI), OSDI and the values recorded in Schirmer's tests were all significantly and positively correlated with the probability of a clinical diagnosis of dry eye (P<0.001 for each). Only patients with a Schirmer's value of <8 mm showed fluorescein staining of the cornea (P<0.005). This appears to be the first report from India in which MMI and OSDI have been significantly correlated with the probability of a clinical diagnosis of dry eye. Although the subjects were recruited in an ophthalmology department and may not have been very representative of the general population of New Delhi, dry-eye syndrome is probably common in the study area and probably has a considerable socio-economic impact. The early detection and timely management of this syndrome is important, as they can help prevent long-term sequelae and sight-threatening complications.

No abstract

No abstract

Background This study assesses the areas and extent of impact of the Coronavirus Disease of 2019 (COVID-19) pandemic on rare disease (RD) organisations in the Asia Pacific region. There is no existing literature that focuses on such impact on RD organisations in any jurisdictions, nor RD populations across multiple jurisdictions in the Asia Pacific region. A cross-sectional survey was distributed to RD organisations between April and May 2020. Quantitative and qualitative data on the impact of COVID-19 on RD organisations and patients were collected from the organisation representative’s perspective. Qualitative data was analysed using thematic analysis. A follow-up focus group meeting was conducted in August 2020 to validate the survey findings and to discuss specific needs, support and recommendations for sustainable healthcare systems during the pandemic. Results A total of 80 RD organisations from Australia, Hong Kong Special Administrative Region of China, India, Japan, mainland China, Malaysia, New Zealand, the Philippines, Singapore and Taiwan participated in the study. Of all, 89% were concerned about the impact of pandemic on their organisations. Results indicate that 63% of the organisations functioned at a reduced capacity and 42% stated a decrease in funding as their biggest challenge. Overall, 95% believed their patients were impacted, particularly in healthcare access, social lives, physical health, psychological health and financial impact. Specifically, 43% identified the reduced healthcare access as their top impact, followed by 26% about the impact on daily living and social life. Focus group meeting discussed differential impact across jurisdictions and point towards telemedicine and digitalisation as potential solutions. Conclusions This serves as the first study to assess the impact of COVID-19 on RD patients and organisations across multiple jurisdictions in the Asia Pacific region, identifying major themes on the impact on both RD patients and organisations. By including 80 organisations from ten jurisdictions, our study presents the most comprehensive assessment of the pandemic’s impact to date. It highlights the need for mental health support and sheds light on moving towards telemedicine and digitalisation of organisation operation, which constitutes a sustainable model in times of pandemics and beyond.